Infusion system for the controlled delivery of therapeutic agents

• US 9,597,449 B2
• Filed: 03/13/2014
• Issued: 03/21/2017
• Est. Priority Date: 03/13/2013
• Status: Active Grant

• Current Assignee: InCube Labs LLC. (In-Cube, Inc.)
• Original Assignee: InCube Labs LLC. (In-Cube, Inc.)
• Inventors: Imran, Mir
• Primary Examiner(s): GILBERT, ANDREW M
• Application Number:
  US14/208,520
• Publication Number:
  US 20140276587A1
• Time in Patent Office: 1,104 Days
• US Class Current: 1/1
• CPC Class Codes: A61M 2005/14204 with gas-producing electrochemical cell
• CPC Class Codes: A61M 2205/3389 Continuous level detection A61M2205/3393 takes precedence
• CPC Class Codes: A61M 2205/3561 local, e.g. within room or hospital
• CPC Class Codes: A61M 2205/3569 sublocal, e.g. between console and disposable
• CPC Class Codes: A61M 2205/3576 with non implanted data transmission devices, e.g. using external transmitter or receiver
• CPC Class Codes: A61M 5/14593 the diaphragm being actuated by fluid pressure
• CPC Class Codes: A61M 5/148 flexible, e.g. independent bagsA61M5/155 takes precedence
• CPC Class Codes: A61M 5/1483 using flexible bags externally pressurised by fluid pressure

Abstract

Embodiments of the invention provide infusion systems for the intravenous or other delivery of drugs and other therapeutic agents to a patient including a human or mammal. The therapeutic agents may be dissolved in solution or comprise the solution itself. Embodiments of the systems can utilize a chemical reaction to predictably drive a flow of drug(s) through a catheter or other flow path and into the patient. More specifically, the reaction may include an acid-base reaction or any other reaction that produces a gaseous substance. The gas is produced and contained in an expandable drive balloon when the acid-base reactants are combined with a liquid. As the gas is produced, the drive balloon expands to exert pressure on a separately-contained drug reservoir which, in turn, pushes drug(s) from the reservoir into the flow path where the drug is ultimately delivered to the patient in a controlled and predetermined manner.

Claims

1. A method for delivering a therapeutic agent to a patient at a flow rate within a pre-determined range, the method comprising:

providing a system for delivering a therapeutic agent solution to the patient, the system having a flow path for flow of the therapeutic agent solution to the patient, the flow path having a selected fluidic resistance, the system including a non-compliant housing containing an enclosed reservoir of therapeutic agent solution coupled to the flow path and a separate expandable balloon which engages the reservoir upon expansion, the expandable balloon having a first and second section separated by a releasable seal extending through the non-compliant housing to be engagable from outside the non-compliant housing, the sections containing a first and second chemical reactant, respectively, which mix to generate a gas and pressure within the expandable balloon upon releasing of the releasable seal, the gas pressure being applied from the expandable balloon to the enclosed therapeutic agent solution reservoir to drive the therapeutic agent solution from the reservoir through the flow path;

wherein the generated pressure and the selected fluidic resistance are configured to deliver the therapeutic agent solution to the patient at the flow rate within the pre-determined range;

engaging the releasable seal from outside the housing to unseparate the first and second sections, wherein the first and second chemical reactants mix and react to generate the gas and pressure for driving the therapeutic agent solution through the flow path; and

using the system and the generated gas pressure to deliver the therapeutic agent solution to the patient at the flow rate within the pre-determined range.

2. The method of claim 1, wherein the flow path comprises a tube or a catheter.

3. The method of claim 1, wherein the flow path includes a hollow needle at a distal end of the flow path.

4. The method of claim 3, wherein the fluidic resistance of the hollow needle controls the flow rate of the therapeutic agent solution.

5. The method of claim 1, wherein the chemical reaction is an acid base reaction.

6. The method of claim 1, wherein the releasable seal is released by means of a pullable tab or pin coupled to the releasable seal.

7. The method of claim 1, wherein the flow rate is between about 10 cc/min and 500 cc/min.

8. The method of claim 1, wherein the flow rate is between about 0.5 cc/min and 20 cc/min.

9. The method of claim 1, wherein the therapeutic agent solution is delivered intravenously to the patient.

10. The method of claim 9, wherein a distal portion of the flow path includes a hollow needle which is inserted into the patient.

11. The method of claim 1, wherein the flow rate remains substantially constant over a period of delivery of therapeutic agent solution to the patient.

12. The method of claim 11, wherein the delivery period comprises a period in which substantially all of a quantity of therapeutic agent solution contained in the system is delivered to the patient.

13. The method of claim 1, wherein the flow rate varies over a period of delivery of therapeutic agent solution to the patient.

14. The method of claim 13, wherein the flow rate is varied by means of a control valve.

15. The method of claim 13, wherein the delivery period includes a first portion having a higher flow rate and a second portion having a lower flow rate.

16. The method of claim 15, wherein a bolus dose of therapeutic agent is delivered during the first portion of the delivery period and a maintenance dose is delivered during the second portion.

17. The method of claim 15, wherein the first portion of the delivery period is up to about two minutes in duration.